Scott M Lippman

12PUBLICATIONS
90CO-AUTHORS
Cancer diagnosisMolecular targetsPredictive and prognostic markersInnate immunityMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 08, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations.

Jason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita

|Dec 19, 2025
Genome-wide CRISPR Screening Reveals a PKA-Driven Resistance Mechanism to Metformin for Oral Cancer Prevention That Can Be Exploited by Combination with NSAIDs.

Thomas S Hoang, Farhoud Faraji, Amaya N Mendez-Molina

|Oct 28, 2024
Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism.

Xingyu Wu, Sendi Rafael Adame-Garcia, Keiichi Koshizuka

|Sep 10, 2024
Integrated Germline and Somatic Features Reveal Divergent Immune Pathways Driving Response to Immune Checkpoint Blockade.

Timothy J Sears, Meghana S Pagadala, Andrea Castro

|Jul 31, 2024
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides.

Erik N Bergstrom, Ammal Abbasi, Marcos Díaz-Gay

Pageof 2